Praxis Precision Medicines Stock Alpha and Beta Analysis
| PRAX Stock | USD 74.68 0.18 0.24% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Praxis Precision Medicines. It also helps investors analyze the systematic and unsystematic risks associated with investing in Praxis Precision over a specified time horizon. Remember, high Praxis Precision's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Praxis Precision's market risk premium analysis include:
Beta 1.16 | Alpha 0.54 | Risk 3.88 | Sharpe Ratio 0.17 | Expected Return 0.68 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Praxis |
Praxis Precision Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Praxis Precision market risk premium is the additional return an investor will receive from holding Praxis Precision long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Praxis Precision. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Praxis Precision's performance over market.| α | 0.54 | β | 1.16 |
Praxis Precision expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Praxis Precision's Buy-and-hold return. Our buy-and-hold chart shows how Praxis Precision performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Praxis Precision Market Price Analysis
Market price analysis indicators help investors to evaluate how Praxis Precision stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Praxis Precision shares will generate the highest return on investment. By understating and applying Praxis Precision stock market price indicators, traders can identify Praxis Precision position entry and exit signals to maximize returns.
Praxis Precision Return and Market Media
The median price of Praxis Precision for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 is 64.94 with a coefficient of variation of 13.24. The daily time series for the period is distributed with a sample standard deviation of 8.64, arithmetic mean of 65.27, and mean deviation of 7.57. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Were Hopeful That Praxis Precision Medicines Will Use Its Cash Wisely | 08/30/2024 |
2 | Acquisition by Nemiroff Alex of 7500 shares of Praxis Precision at 1.63 subject to Rule 16b-3 | 09/20/2024 |
3 | Praxis Precision Medicines Moves 8.4 percent Higher Will This Strength Last | 10/04/2024 |
4 | Disposition of 3057 shares by Ravina Bernard of Praxis Precision at 12.85 subject to Rule 16b-3 | 10/17/2024 |
5 | Were Not Very Worried About Praxis Precision Medicines Cash Burn Rate | 10/21/2024 |
6 | Vanguard Group Incs Strategic Acquisition in Praxis Precision Medicines Inc | 11/05/2024 |
7 | Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2024 Financial Results | 11/06/2024 |
8 | Praxis Precision Medicines Inc Q3 2024 Earnings Call Highlights Strong Cash Position ... | 11/07/2024 |
9 | Piper Sandler maintains stock target on PRAX, confident in ET drug | 11/12/2024 |
10 | Disposition of 5188 shares by Lauren Mastrocola of Praxis Precision at 81.783 subject to Rule 16b-3 | 11/14/2024 |
11 | RA Capital Management Reduces Stake in Praxis Precision Medicines Inc | 11/15/2024 |
12 | Praxis Precision Medicines Shares Gap Down After Insider Selling - MarketBeat | 11/18/2024 |
About Praxis Precision Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Praxis or other stocks. Alpha measures the amount that position in Praxis Precision Med has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | PB Ratio | 3.33 | 1.44 | 2.11 | 1.62 | Capex To Depreciation | 5.77 | 1.06 | 0.12 | 0.11 |
Praxis Precision Upcoming Company Events
As portrayed in its financial statements, the presentation of Praxis Precision's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Praxis Precision's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Praxis Precision's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Praxis Precision. Please utilize our Beneish M Score to check the likelihood of Praxis Precision's management manipulating its earnings.
| 6th of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 6th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Praxis Precision
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.